Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

492 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy.
Serebruany VL, Malinin AI, Callahan KP, Binbrek A, Van De Werf F, Alexander JH, Granger CB, Gurbel PA; Assessment of the Safety and Efficacy of a New Thrombolytic Agent platelet substudy. Serebruany VL, et al. Among authors: gurbel pa. Am Heart J. 2003 Apr;145(4):636-42. doi: 10.1067/mhj.2003.210. Am Heart J. 2003. PMID: 12679759 Clinical Trial.
Relation of platelet activation and myocardial ischemia biomarkers dependent on type of chest pain (abrupt onset versus intermittent) in patients with angina pectoris or non-Q-wave acute myocardial infarction.
Bahr RD, Gurbel PA, Malinin AI, Wentz C, Christenson RH, Roe MT, Gibler WB, Kitt MM, Ohman EM, Serebruany VL. Bahr RD, et al. Among authors: gurbel pa. Am J Cardiol. 2002 Aug 1;90(3):310-2. doi: 10.1016/s0002-9149(02)02470-0. Am J Cardiol. 2002. PMID: 12127619 No abstract available.
Failure of platelet parameters and biomarkers to correlate platelet function to severity and etiology of heart failure in patients enrolled in the EPCOT trial. With special reference to the Hemodyne hemostatic analyzer. Whole Blood Impedance Aggregometry for the Assessment of Platelet Function in Patients with Congestive Heart Failure.
Serebruany VL, McKenzie ME, Meister AF, Fuzaylov SY, Gurbel PA, Atar D, Gattis WA, O'Connor CM. Serebruany VL, et al. Among authors: gurbel pa. Pathophysiol Haemost Thromb. 2002 Jan-Feb;32(1):8-15. doi: 10.1159/000057283. Pathophysiol Haemost Thromb. 2002. PMID: 12214158 Free article. Clinical Trial.
Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).
Serebruany VL, Malinin AI, O'connor CM, Gurbel PA; Roxifiban Oral Compound Kinetics Evaluation Trial-I Platelet Substudy. Serebruany VL, et al. Among authors: gurbel pa. Am Heart J. 2003 Jul;146(1):91-8. doi: 10.1016/S0002-8703(03)00186-8. Am Heart J. 2003. PMID: 12851613 Clinical Trial.
492 results